Hamel Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
29,707
+17,435
+142% +$1.59M 0.74% 40
2026
Q1
$1.26M Hold
12,272
0.36% 49
2025
Q4
$1.54M Sell
12,272
-220
-2% -$28K 0.46% 45
2025
Q3
$1.67M Sell
12,492
-154
-1% -$20.2K 0.51% 44
2025
Q2
$1.72M Buy
12,646
+154
+1% +$20.3K 0.58% 41
2025
Q1
$1.66M Sell
12,492
-75
-0.6% -$9.54K 0.56% 47
2024
Q4
$1.42M Sell
12,567
-675
-5% -$78K 0.46% 48
2024
Q3
$1.51M Sell
13,242
-1,375
-9% -$151K 0.46% 50
2024
Q2
$1.52M Sell
14,617
-2,596
-15% -$275K 0.48% 48
2024
Q1
$1.96M Sell
17,213
-1,275
-7% -$146K 0.63% 46
2023
Q4
$2.03M Sell
18,488
-1,320
-7% -$132K 0.72% 43
2023
Q3
$1.92M Buy
19,808
+800
+4% +$84K 0.7% 43
2023
Q2
$2.07M Sell
19,008
-4,320
-19% -$460K 0.73% 45
2023
Q1
$2.36M Sell
23,328
-13,495
-37% -$1.42M 0.82% 42
2022
Q4
$4.04M Sell
36,823
-1,540
-4% -$159K 1.41% 30
2022
Q3
$3.71M Buy
38,363
+7,450
+24% +$794K 1.47% 26
2022
Q2
$3.36M Sell
30,913
-175
-0.6% -$19.9K 1.32% 28
2022
Q1
$3.68M Sell
31,088
-144
-0.5% -$17.9K 1.31% 29
2021
Q4
$4.4M Buy
31,232
+175
+0.6% +$22.4K 1.58% 24
2021
Q3
$3.67M Sell
31,057
-2,520
-8% -$310K 1.43% 27
2021
Q2
$3.89M Sell
33,577
-1,325
-4% -$154K 1.48% 28
2021
Q1
$4.18M Buy
34,902
+1,525
+5% +$181K 1.61% 28
2020
Q4
$3.65M Buy
33,377
+117
+0.4% +$12.7K 1.5% 27
2020
Q3
$3.62M Buy
33,260
+675
+2% +$68.5K 1.61% 24
2020
Q2
$2.98M Hold
32,585
1.43% 26
2020
Q1
$2.57M Buy
32,585
+11,885
+57% +$992K 1.36% 30
2019
Q4
$1.8M Hold
20,700
0.74% 42
2019
Q3
$1.73M Hold
20,700
0.74% 43
2019
Q2
$1.74M Sell
20,700
-400
-2% -$31.5K 0.76% 43
2019
Q1
$1.69M Sell
21,100
-1,100
-5% -$81.8K 0.76% 44
2018
Q4
$1.6M Hold
22,200
0.8% 40
2018
Q3
$1.63M Hold
22,200
0.71% 50
2018
Q2
$1.35M Hold
22,200
0.62% 48
2018
Q1
$1.33K Sell
22,200
-175
-0.8% -$10.5K 0.09% 47
2017
Q4
$1.28M Hold
22,375
0.6% 45
2017
Q3
$1.19M Hold
22,375
0.58% 47
2017
Q2
$1.09M Buy
22,375
+1,100
+5% +$49.8K 0.55% 46
2017
Q1
$945K Buy
21,275
+6,775
+47% +$293K 0.48% 50
2016
Q4
$557K Sell
14,500
-250
-2% -$9.91K 0.29% 58
2016
Q3
$624K Hold
14,750
0.33% 56
2016
Q2
$580K Hold
14,750
0.3% 61
2016
Q1
$617K Hold
14,750
0.33% 59
2015
Q4
$662K Buy
14,750
+250
+2% +$11K 0.42% 55
2015
Q3
$583K Hold
14,500
0.41% 60
2015
Q2
$712K Hold
14,500
0.47% 61
2015
Q1
$671K Hold
14,500
0.44% 67
2014
Q4
$653K Sell
14,500
-1,400
-9% -$61K 0.42% 62
2014
Q3
$661K Sell
15,900
-2,325
-13% -$98.4K 0.44% 65
2014
Q2
$742K Sell
18,225
-5,225
-22% -$205K 0.49% 63
2014
Q1
$702K Buy
23,450
+6,825
+41% +$263K 0.49% 64
2013
Q4
$637K Buy
+16,625
New +$613K 0.45% 66

Other funds holding ABT

Hamel Associates's ABT Position: Q2 2026 in Review

Hamel Associates increased its Abbott (ABT) stake by 142% in Q2 2026, buying an estimated $1.59M and bringing the position to 29,707 shares worth $2.7M. The position accounts for 0.74% of the portfolio, ranked #40.

Hamel Associates first reported a position in ABT in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.4M in Q4 2021. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Hamel Associates held 29,707 shares of Abbott worth $2.7M as of Q2 2026.
  • Hamel Associates bought 17,435 Abbott shares in Q2 2026, an estimated $1.59M.
  • Abbott made up 0.74% of Hamel Associates's portfolio in Q2 2026, its #40 holding.
  • Hamel Associates first reported a position in Abbott in Q4 2013 and has held it in 51 quarters since.
  • Hamel Associates's Abbott position peaked at $4.4M in Q4 2021.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.